[Corrections] Correction to Lancet Infect Dis 2025; 25: 986–99

Wagner L, Obersriebnig M, Kadlecek V, et al. Immunogenicity and safety of different immunisation schedules of the VLA15 Lyme borreliosis vaccine candidate in adults, adolescents, and children: a randomised, observer-blind, placebo-controlled, phase 2 trial. Lancet Infect Dis 2025; 25: 986–99—In this Article, figure 1 has been updated to fix indenting errors in the top-right box. This correction has been made to the online version as of Sept 22, 2025.